|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01952 EVEREST MED
Nominal 
59.050 -1.150 (-1.910%) | 2025/06 - Interim RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | -- | (679,513) | (769,190) | (1,155,761) | (729,936) |
| Net Cash from / (used in) Investing Activities | -- | 974,396 | 752,497 | (1,028,025) | (975,816) |
| Net Cash from / (used in) Financing Activities | -- | 37,800 | 10,103 | (25,311) | (76,508) |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | 332,683 | (6,590) | (2,209,097) | (1,782,260) |
| Cash & Cash Equivalents at beginning of period | -- | 523,063 | 490,788 | 2,640,053 | 4,481,122 |
| Effect of Foreign Exchange Rate Changes | -- | 28,722 | 38,865 | 59,832 | (58,809) |
| Others | -- | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 884,468 | 523,063 | 490,788 | 2,640,053 |
| Remarks: | Real time quote last updated: 11/09/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -249,790 |
| %Change | -60.502% |
| EPS / (LPS) | RMB -0.770 |
| NBV Per Share (¥) | RMB 11.981 |